Article
Evaluation of a Congenital Infantile Fibrosarcoma by Comprehensive Genomic Profiling Reveals an LMNA-NTRK1 Gene Fusion Responsive to Crizotinib
12 Nov 2015
Abstract excerpt
We present a case of a reverse transcription polymerase chain reaction (RT-PCR) ETV6-NTRK3 negative congenital infantile fibrosarcoma (CIFS) harboring an LMNA-NTRK1 gene fusion with an eight-month ongoing, near-complete response to crizotinib. CIFS is a rare, typically low-grade sarcoma of children younger than age two years and is associated with a good to excellent prognosis, with an 80% median five-year...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
